CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Atrial fibrillation - Management
When should I offer antithrombotic treatment?
- All people with atrial fibrillation (whether paroxysmal, persistent, or permanent) should be offered antithrombotic treatment to reduce their risk of stroke.
- Offer either aspirin or warfarin, without delay, after confirming a diagnosis of atrial fibrillation.
- The choice of either aspirin or warfarin should be based on the person's risk of stroke (see Which antithrombotic treatment).
In depth
© NHS Institute for Innovation and Improvement